NCT07219927View on ClinicalTrials.gov

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions
Parkinson Disease
Interventions
OTHER

Observational study

Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM)

Trial Locations (5)

11725

RECRUITING

Parkinson's Disease and Movement Disorders Center - Long Island, Commack

33486

RECRUITING

Parkinson's Disease & Movement Disorders Center of Boca Raton, Boca Raton

92618

RECRUITING

Parkinson's Disease and Movement Disorders Center - Orange County (North), Irvine

92656

RECRUITING

Parkinson's Disease and Movement Disorders Center - Orange County (South), Aliso Viejo

94301

RECRUITING

Parkinson's Research Centers of America - Palo Alto, Palo Alto

All Listed Sponsors
lead

Supernus Pharmaceuticals, Inc.

INDUSTRY